Cannvalate is proudly established as Australia’s first patient-facing medicinal cannabis company bridging the gap between demand and access to evidence-based medicine.

Cannvalate strives to improve patient quality of life by advancing medicinal cannabis companies to produce and maintain optimum quality and consistent end-product. We are also educating and empowering medical professionals and streamlining processes for prescribing and monitoring to patients.

The Cannvalate team and advisory board comprises of Australia’s top leaders and subject matter experts responsible for prescribing over 90% of the medicinal cannabis in Australia to date.